Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Unilateral Bevacizumab for Bilateral Diabetic Macular Edema
NCT00496405Phase 4Withdrawn
- Sponsor
- Asociación para Evitar la Ceguera en México
- Start
- Apr 2007
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of bevacizumab in diabetic macular edema (DME), sponsored by Asociación para Evitar la Ceguera en México. Planned start Apr 2007; status: withdrawn.
02
Drugs
bevacizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT00496405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00496405.